Globus Medical, Inc.

$80.91 USD

$2.35 (2.99%)

Volume: 1.95M
Average Volume: 1.77M
Market Capitalization: $10.91B
P/E Ratio: 18.60
Dividend Yield: 0.00%
Price Target: $101.50

Year High: $101.40
Year Low: $51.79
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $4.56

Industry, Sector & symbol

Stock Exchange	NYSE
CEO	Keith W. Pfeil
Industry	Medical - Devices
Sector	Healthcare
Current Symbol	GMED
CUSIP	379577208
CIK	0001237831
Web	https://www.globusmedical.com
Phone	610 930 1800
Currency	USD
Employees	6000
Country	US

Liquidity

Debt-to-Equity Ratio	0.02
Payout Ratio	0.00
Current Ratio	4.56
Quick Ratio	2.95
Cash Ratio	1.16

Sales & Book Value

Annual Sales	$2.94B
Price / Sales	3.52
Cash Flow	4.43
Price / Cash Flow	18.18
Price / Book	2.31

Price Target and Rating

Average Stock Price Forecast	$101.50
High Stock Price Forecast	$117.00
Low Stock Price Forecast	$80.00
Forecast Upside/Downside	-20.29%
Consensus Rating	Buy
Rating Score(0-5)	4
Research Coverage	36 Analysts

Profitability

EPS (Most Recent Fiscal Year)	$3.92
Trailing P/E Ratio	18.60
PEG Ratio	0.08
P/E Growth	0.08
Net Income	$537.9M
Net Margin	18.92%
Pretax Margin	21.39%
Return on Equity	13.04%
Return on Assets	10.79%

Financials Score

AltmanZ Score	10.69
Piotroski Score	8.00
Working Capital	1.72B
Total Assets	5.44B
Ebit	597.94M
Market Cap	10.59B
Total Liabilities	707.24M

Poll Results

About Globus Medical, Inc. (NYSE:GMED) Stock

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fr ... actures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm

2026-07-16 21:02:00

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

2026-07-16 16:30:00

AUDUBON, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2026 after the market close on Thursday, August 6, 2026.

Here's Why Globus Medical (GMED) is a Strong Value Stock

2026-07-16 10:40:23

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

2026-07-01 10:51:22

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

GMED vs. MDT: Which Medical Stock Has More Upside Potential?

2026-06-29 14:41:17

Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside may give it the edge despite a richer valuation.

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

2026-06-26 10:41:16

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

2026-06-22 12:41:09

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?

Here's How Macro Trends and Currency Headwind Restrict GMED's Growth

2026-06-22 11:31:28

Globus Medical faces inflation, geopolitical and currency pressures as rising costs and FX losses cloud margin flexibility and international growth.

Frequently Asked Questions

What is the current Globus Medical, Inc. (GMED) stock price?: Globus Medical, Inc.(NYSE:GMED) stock price is $80.91 in the last trading session. During the trading session, GMED stock reached the peak price of $101.4 while $51.79 was the lowest point it dropped to. The percentage change in GMED stock occurred in the recent session was 2.99% while the dollar amount for the price change in GMED stock was $2.35.
GMED's industry and sector of operation?: The NYSE listed GMED is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of GMED?: Kyle R. Klin | Senior Vice President & Chief Financial Officer
Keith W. Pfeil | Chief Executive Officer, President & Director
Kelly G. Huller | Executive Vice President, General Counsel & Corporate Secretary
David C. Paul | Co-Founder & Executive Chairman
Brian J. Kearns | Senior Vice President of Business Development & Investor Relations
How many employees does GMED have?: Number of GMED employees currently stands at 6000. GMED operates from 2560 General Armistead Avenue, Audubon, PA 19403, US.

Link for GMED official website?: Official Website of GMED is: https://www.globusmedical.com
How do I contact GMED?: GMED could be contacted at phone #610 930 1800 and can also be accessed through its website. GMED operates from 2560 General Armistead Avenue, Audubon, PA 19403, US.
How many shares of GMED are traded daily?: The average number of GMED shares traded daily for last 3 months was 1.77M.
What is the market cap of GMED currently?: The market value of GMED currently stands at $10.91B with its latest stock price at $80.91